Gene therapy for lysosomal storage disorders

被引:25
|
作者
Gritti, Angela [1 ]
机构
[1] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy
关键词
CNS; gene delivery; gene therapy; lysosomal storage disorders; viral vectors; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADENOASSOCIATED VIRUS VECTOR; ENZYME REPLACEMENT THERAPY; BONE-MARROW-TRANSPLANTATION; NONHUMAN PRIMATE BRAIN; MOUSE MODEL; LONG-TERM; LENTIVIRAL VECTORS; IMMUNE-RESPONSES;
D O I
10.1517/14712598.2011.582036
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Areas covered: Based on an extensive literature search up until March 2011, the author reviews and discusses the progress, the crucial aspects and the major challenges towards the development of novel gene therapy strategies aimed to target the CNS, with particular attention to direct intracerebral gene delivery and transplantation of neural stem/progenitor cells. Expert opinion: The implementation of viral vector delivery systems with specific tropism, regulated transgene expression, low immunogenicity and low genotoxic risk and the improvement in isolation and manipulation of relevant cell types to be transplanted, are fundamental challenges to the field. Also, combinatorial strategies might be required to achieve full correction in LSDs with neurological involvement.
引用
收藏
页码:1153 / 1167
页数:15
相关论文
共 50 条
  • [41] Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
    Penati, Rachele
    Fumagalli, Francesca
    Calbi, Valeria
    Bernardo, Maria Ester
    Aiuti, Alessandro
    JOURNAL OF INHERITED METABOLIC DISEASE, 2017, 40 (04) : 543 - 554
  • [42] Safety of Lysosomal Enzymes Over-Expression in HSC for Gene Therapy of Storage Disorders
    Biffi, Alessandra
    Visigalli, Ilaria
    Cesani, Martina
    Capotondo, Alessia
    de Sio, Francesca R. Santoni
    Pallavicini, Isabella
    Zingale, Anna
    Naldini, Luigi
    MOLECULAR THERAPY, 2006, 13 : S157 - S157
  • [43] Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases
    Tomanin, Rosella
    Zanetti, Alessandra
    Zaccariotto, Eva
    D'Avanzo, Francesca
    Bellettato, Cinzia M.
    Scarpa, Maurizio
    ACTA PAEDIATRICA, 2012, 101 (07) : 692 - 701
  • [44] Gene transfer strategies for correction of lysosomal storage disorders
    d'Azzo, A
    ACTA HAEMATOLOGICA, 2003, 110 (2-3) : 71 - 85
  • [45] Particularities of lysosomal storage diseases gene therapy
    Poenaru, L
    GENE THERAPY, 1996, 3 (12) : 1039 - 1041
  • [46] In utero enzyme replacement therapy for lysosomal storage disorders
    Herzeg, A.
    Borges, B.
    Lianoglou, B. R.
    Gonzalez-Velez, J.
    Young, S.
    Gelb, M.
    Herbst, Z.
    Canepa, E.
    Munar, D.
    Bali, D.
    Chakraborty, P.
    Cohen, J. L.
    Kishnani, P.
    Harmatz, P.
    MacKenzie, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 408 - 408
  • [47] Lysosomal storage disorders. Pathogenesis, symptoms and therapy
    Beck, M.
    MONATSSCHRIFT KINDERHEILKUNDE, 2011, 159 (09) : 821 - 826
  • [48] Central nervous system therapy for lysosomal storage disorders
    Enns, Gregory M.
    Huhn, Stephen L.
    NEUROSURGICAL FOCUS, 2008, 24 (3-4)
  • [49] Enzyme replacement therapy for lysosomal storage disorders in India
    Mamta Muranjan
    Molecular Cytogenetics, 7 (Suppl 1)
  • [50] Enzyme replacement therapy for lysosomal storage disorders - Reply
    Pindolia, Kirit
    Wolf, Barry
    HUMAN GENE THERAPY, 2008, 19 (08) : 858 - 858